Cargando…

Identification of a DNA Damage Response and Repair-Related Gene-Pair Signature for Prognosis Stratification Analysis in Hepatocellular Carcinoma

Background: Nowadays, although the cause of hepatocellular carcinoma (HCC) mortality and recurrence remains at a high level, the 5-year survival rate is still very low. The DNA damage response and repair (DDR) pathway may affect HCC patients’ survival by influencing tumor development and therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yi, Huang, Mengjia, Zhu, Junkai, Xu, Li, Cheng, Wenxuan, Lu, Xiaofan, Yan, Fangrong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9038539/ https://www.ncbi.nlm.nih.gov/pubmed/35496321 http://dx.doi.org/10.3389/fphar.2022.857060

Ejemplares similares

Prognosis stratification and personalized treatment in bladder cancer through a robust immune gene pair‐based signature
por: Lu, Xiaofan, et al.
Publicado: (2021)

Identification and validation of an inflammation-related lncRNAs signature for improving outcomes of patients in colorectal cancer
por: Huang, Mengjia, et al.
Publicado: (2022)

An anoikis-based signature for predicting prognosis in hepatocellular carcinoma with machine learning
por: Guizhen, Zhang, et al.
Publicado: (2023)

Identification of Immune-Related Subtypes and Characterization of Tumor Microenvironment Infiltration in Bladder Cancer
por: Huang, Mengjia, et al.
Publicado: (2021)

Identification and validation of a novel cuproptosis-related genes signature associated with prognosis, clinical implications and immunotherapy of hepatocellular carcinoma
por: He, Fengjiao, et al.
Publicado: (2023)

Title: Multi-Omics and Immune Landscape of Proliferative LncRNA Signatures: Implications for Risk Stratification and Immunotherapy in Hepatocellular Carcinoma
por: Liu, Chi, et al.
Publicado: (2022)

Multi-Omics Integrative Analysis of Lung Adenocarcinoma: An in silico Profiling for Precise Medicine
por: Ruan, Xinjia, et al.
Publicado: (2022)

DNA damage repair-related gene signature for identifying the immune status and predicting the prognosis of hepatocellular carcinoma
por: Lu, Yongpan, et al.
Publicado: (2023)

Identification of Immune Function-Related Subtypes in Cutaneous Melanoma
por: Liu, Lin, et al.
Publicado: (2021)

DNA Damage Repair Status Predicts Opposite Clinical Prognosis Immunotherapy and Non-Immunotherapy in Hepatocellular Carcinoma
por: Chen, Yunfei, et al.
Publicado: (2021)

Multi‐omics consensus ensemble refines the classification of muscle‐invasive bladder cancer with stratified prognosis, tumour microenvironment and distinct sensitivity to frontline therapies
por: Lu, Xiaofan, et al.
Publicado: (2021)

An m6A-Related lncRNA Signature Predicts the Prognosis of Hepatocellular Carcinoma
por: Zhang, Zhenyu, et al.
Publicado: (2022)

Ubiquitin-proteasome system-based signature to predict the prognosis and drug sensitivity of hepatocellular carcinoma
por: Zhang, Jianxiang, et al.
Publicado: (2023)

Identification of a DNA damage repair gene‐related signature for lung squamous cell carcinoma prognosis
por: Jia, Bin, et al.
Publicado: (2022)

Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in ER (+) and/or PR (+) and HER2 (−) Breast Cancer
por: Du, Feng, et al.
Publicado: (2022)

Prognostic value of DNA repair based stratification of hepatocellular carcinoma
por: Lin, Zhuo, et al.
Publicado: (2016)

Autophagy-Related Gene Pairs Signature for the Prognosis of Hepatocellular Carcinoma
por: Luo, Yiming, et al.
Publicado: (2021)

Novel Hypoxia-Related Gene Signature for Risk Stratification and Prognosis in Hepatocellular Carcinoma
por: Li, Quanxiao, et al.
Publicado: (2021)

A Novel Epithelial-Mesenchymal Transition Gene Signature Correlated With Prognosis, and Immune Infiltration in Hepatocellular Carcinoma
por: Kong, Weihao, et al.
Publicado: (2022)

Identification and Validation of a Novel DNA Damage and DNA Repair Related Genes Based Signature for Colon Cancer Prognosis
por: Wang, Xue-quan, et al.
Publicado: (2021)

Identification of DNA repair gene signature and potential molecular subtypes in hepatocellular carcinoma
por: Bai, Yi, et al.
Publicado: (2023)

Identification pyroptosis-related gene signature to predict prognosis and associated regulation axis in colon cancer
por: Zhou, Kexun, et al.
Publicado: (2022)

A Novel DNA Damage Repair-Related Gene Signature for Predicting Glioma Prognosis
por: Zhan, Jiaoyang, et al.
Publicado: (2021)

Identification of a novel lncRNA prognostic signature and analysis of functional lncRNA AC115619.1 in hepatocellular carcinoma
por: Gan, Binliang, et al.
Publicado: (2023)

Identification of lncRNA Signature of Tumor-Infiltrating T Lymphocytes With Potential Implications for Prognosis and Chemotherapy of Head and Neck Squamous Cell Carcinoma
por: Wang, Liping, et al.
Publicado: (2022)

A novel NHEJ gene signature based model for risk stratification and prognosis prediction in hepatocellular carcinoma
por: Lin, Zhu, et al.
Publicado: (2023)

UBA1 inhibition contributes radiosensitization of glioblastoma cells via blocking DNA damage repair
por: Wu, Changyong, et al.
Publicado: (2023)

A signature of immune-related gene pairs (IRGPs) for risk stratification and prognosis of oral cancer patients
por: Yu, Yanling, et al.
Publicado: (2022)

A glycolysis-related gene pairs signature predicts prognosis in patients with hepatocellular carcinoma
por: Zhou, Weige, et al.
Publicado: (2020)

A signature of 13 autophagy‑related gene pairs predicts prognosis in hepatocellular carcinoma
por: Cao, Jie, et al.
Publicado: (2021)

LncRNA LINC01134 Contributes to Radioresistance in Hepatocellular Carcinoma by Regulating DNA Damage Response via MAPK Signaling Pathway
por: Wang, Zhiyi, et al.
Publicado: (2022)

Identification of PANoptosis-Based Prognostic Signature for Predicting Efficacy of Immunotherapy and Chemotherapy in Hepatocellular Carcinoma
por: Xiong, Xiaofeng, et al.
Publicado: (2023)

Identification and validation of prognosis-associated DNA repair gene signatures in colorectal cancer
por: Song, Dingli, et al.
Publicado: (2022)

Targeting Mouse Double Minute 2: Current Concepts in DNA Damage Repair and Therapeutic Approaches in Cancer
por: Li, Wen, et al.
Publicado: (2020)

DNA damage repair gene signature model for predicting prognosis and chemotherapy outcomes in lung squamous cell carcinoma
por: Wang, Xinshu, et al.
Publicado: (2022)

Effects of Glycolysis-Related Genes on Prognosis and the Tumor Microenvironment of Hepatocellular Carcinoma
por: Zheng, Ju-Yan, et al.
Publicado: (2022)

Integrated analysis of single-cell and bulk RNA-sequencing reveals tumor heterogeneity and a signature based on NK cell marker genes for predicting prognosis in hepatocellular carcinoma
por: Li, Shuo, et al.
Publicado: (2023)

A novel tumor immunotherapy-related signature for risk stratification, prognosis prediction, and immune status in hepatocellular carcinoma
por: Sun, Jianping, et al.
Publicado: (2023)

A novel qualitative signature based on lncRNA pairs for prognosis prediction in hepatocellular carcinoma
por: Bu, Xiaoyun, et al.
Publicado: (2022)

Identification of a novel ferroptosis-related gene signature associated with prognosis, the immune landscape, and biomarkers for immunotherapy in ovarian cancer
por: Liu, Yilong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6hl2k8ehti42ed5jprul38chnc